Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Cervical Cancer

  • Chapter
  • First Online:
Handbook of Evidence-Based Radiation Oncology

Abstract

This chapter will discuss the epidemiology, workup, staging, treatment recommendations, key studies and radiation treatment techniques for cervical cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Charra-Brunaud C, Harter V, Delannes M, et al. Impact of 3D image-based PDR brachytherapy on outcome of pts treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol. 2012;103(3):305–13.

    Article  Google Scholar 

  • Dueñas-González A, Zarbá JJ, Patel F, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678–85.

    Article  Google Scholar 

  • Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging handbook. New York: Springer; 2011.

    Google Scholar 

  • Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004;22:872–80.

    Article  Google Scholar 

  • Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805–14.

    Article  Google Scholar 

  • Gill BS, Lin JF, Krivak TC, et al. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. Int J Radiat Oncol Biol Phys. 2014;90(5):1083–90.

    Article  Google Scholar 

  • Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005;74(3):235–45.

    Article  Google Scholar 

  • Han K, Milosevic M, Fyles A, Pintilie M, Viswanathan AN. Trends in the utilization of brachytherapy in cervical cancer in the United States. Int J Radiat Oncol Biol Phys. 2013;87(1):111–9.

    Article  Google Scholar 

  • Hanks GE, Herring DF, Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer. 1983;51(5):959–67.

    Article  CAS  Google Scholar 

  • Hsu IJ, Swift PS. Cancer of the uterine cervix. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 3rd ed. Philadelphia: Saunders; 2010. p. 1002–25.

    Chapter  Google Scholar 

  • Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340:1154–61.

    Article  CAS  Google Scholar 

  • Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the gynecologic oncology group. Gynecol Oncol. 2003;89:343–53.

    Article  Google Scholar 

  • Lanciano RM, Martz K, Coia LR, Hanks GE. Tumor and treatment factors improving outcome in stage III-B cervix cancer. Radiat Oncol Biol. 1991;20(1):95–100.

    Article  CAS  Google Scholar 

  • Lanciano R, Calkins A, Bundy BN, et al. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol. 2005;23:8289–95.

    Article  CAS  Google Scholar 

  • Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–40.

    Article  CAS  Google Scholar 

  • Lee LJ, Das IJ, Higgins SA, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy. Brachytherapy. 2012;11:53–7.

    Article  Google Scholar 

  • Lim K, Small W Jr, Portelance L, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Int J Radiat Oncol Biol Phys. 2011;79:348–55.

    Google Scholar 

  • Logsdon MD, Eifel PJ. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Radiat Oncol Biol. 1999;43(4):763–75.

    Article  CAS  Google Scholar 

  • Mayadev J, Viswanathan A, Liu Y, et al. American Brachytherapy Task Group Report: a pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer. Brachytherapy. 2017;16:22–43.

    Article  Google Scholar 

  • Monk BJ, Wang J, Im S, et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial. Gynecol Oncol. 2005;96(3):721–8.

    Article  Google Scholar 

  • Montana GS, Fowler WC, Varia MA, Walton LA, Mack Y, Shemanski L. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer. 1986;57(1):148–54.

    Article  CAS  Google Scholar 

  • Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–43.

    Article  CAS  Google Scholar 

  • National Cancer Institute Surveillance. Epidemiology, and End Results Program (SEER). 2016. http://seer.cancer.gov/statfacts/html/corp.html. Accessed 22 Aug 2016.

  • National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2016). 2016. https://www.nccn.org/professionals/physician_gls/pdf/cervical.pdf. Accessed 27 Aug 2016.

  • PDQ Screening and Prevention Editorial Board. Cervical Cancer Screening (PDQ®): Health Professional Version. 4 Mar 2016.

    Google Scholar 

  • Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in pts with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20:966–72.

    Article  CAS  Google Scholar 

  • Peters WA III, Liu PY, Barrett RJ II, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13.

    Article  CAS  Google Scholar 

  • Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006;78(1):67–77.

    Article  Google Scholar 

  • Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53.

    Article  CAS  Google Scholar 

  • Rose PG, Ali S, Watkins E, et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a gynecologic oncology group study. J Clin Oncol. 2007;25:2804–10.

    Article  CAS  Google Scholar 

  • Rose PG, Java J, Whitney CW, et al. Nomograms Predicting Progression-Free Survival, Overall Survival, and Pelvic Recurrence in Locally Advanced Cervical Cancer Developed From an Analysis of Identifiable Prognostic Factorsin Patients From NRG Oncology/Gynecologic Oncology Group Randomized Trials of Chemoradiotherapy. J Clin Oncol. 2015;33:2136–42.

    Article  Google Scholar 

  • Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-yr treatment results of RTOG 79-20. JAMA. 1995;274:387–93.

    Article  CAS  Google Scholar 

  • Rotman M, Sedlis A, Piedmonte MR, et al. A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2006;65:169–76.

    Article  Google Scholar 

  • Ryu S-Y, Lee W-M, Kim K, et al. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2011;81(4):e577–81.

    Article  CAS  Google Scholar 

  • Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected pts with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study. Gynecol Oncol. 1999;73:177–83.

    Article  CAS  Google Scholar 

  • SEER Cancer Statistics Review, 1975–2012. National Cancer Institute. 2016. http://seer.cancer.gov/archive/csr/1975_2012/results_merged/sect_05_cervix_uteri.pdf. Accessed 26 Aug 2016.

  • Serrano B, Alemany L, Tous S, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer. 2012;7(1):38.

    Article  Google Scholar 

  • Stehman FB, Ali S, Keys HM, et al. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a gynecologic oncology group trial. Am J Obstet Gynecol. 2007;197(5):503.e1–6.

    Article  Google Scholar 

  • Suneja G, Brown D, Chang A, et al. American Brachytherapy Society: brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries. Brachytherapy. 2017;16:85–94.

    Article  Google Scholar 

  • The American Cancer Society guidelines for the prevention and early detection of cervical cancer. 2016. http://www.cancer.org/cancer/cervicalcancer/moreinformation/cervicalcancerpreventionandearlydetection/cervical-cancer-prevention-and-early-detection-cervical-cancer-screening-guidelines. Accessed 26 Aug 2016.

  • Vargo JA, Kim H, CHOI S, et al. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era. Int J Radiat Oncol Biol Phys. 2014;90(5):1091–8.

    Article  Google Scholar 

  • Viswanathan AN and Thomadsen B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles. Brachytherapy. 2012;11:33–46.

    Article  Google Scholar 

  • Viswanathan AN, Beriwal S, De Los Santos JF, et al. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy. Brachytherapy. 2012;11:47–52.

    Article  Google Scholar 

  • Viswanathan AN. Uterine cervix. In: Halperin CE, Wazer DE, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1355–425.

    Google Scholar 

  • Viswanathan AN, Erickson B, Gaffney DK, et al. Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys. 2014;90(2):320–8.

    Article  Google Scholar 

  • Viswanathan AN, Dizon DS, Gien LT, Koh W. Cervical cancer. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 4th ed. Philadelphia: Churchill Livingstone; 2015. p. 1173–1202.e6.

    Google Scholar 

  • Wang C-C, Lai C-H, Huang Y-T, Chao A, Chou H-H, Hong J-H. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2012;84(4):e499–506.

    Article  Google Scholar 

  • Whitney CW, Sause W. Randomized comparison of fluorouracil plus Cisplatin versus Hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study. 1999:1137-1143. J Clin Oncol. 1999;17(5):1339–48.

    Article  CAS  Google Scholar 

Download references

Acknowledgment

We thank R. Scott Bermudez MD and Kim Huang MD for their work on the prior edition of this chapter.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA

    Serah Choi & I-Chow J. Hsu

Authors
  1. Serah Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I-Chow J. Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I-Chow J. Hsu .

Editor information

Editors and Affiliations

  1. The Oregon Clinic, Providence St. Vincent Medical Center, Portland, OR, USA

    Eric K. Hansen

  2. Department of Radiation Oncology, University of California, San Franc, SAN FRANCISCO, CA, USA

    Mack Roach III

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Choi, S., Hsu, IC.J. (2018). Cervical Cancer. In: Hansen, E., Roach III, M. (eds) Handbook of Evidence-Based Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-62642-0_29

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62642-0_29

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62641-3

  • Online ISBN: 978-3-319-62642-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation